Navigation Links
Researchers Find Link Between Organ Transplants, Cancer
Date:7/16/2008

Immune-suppressing drugs may trigger protein that boosts tumor growth, study finds

WEDNESDAY, July 16 (HealthDay News) -- Anti-rejection drugs given after organ transplants may be the reason why 15 percent to 20 percent of individuals who receive such transplants have a higher risk of developing cancer within the next decade.

The good news is that targeted therapies could diminish the risk, said Harvard researchers reporting in the July 15 issue of Cancer Research.

The tumors themselves may have already existed before the transplant procedure or they may be a return of an old cancer. An immune system dampened by immunosuppressive drugs could make it easier for both scenarios to take place. On the other hand, a virus introduced from the donor organ may have precipitated the cancer, the researchers said.

And heightened production of vascular endothelial growth factor (VEGF) after the transplant may also be a factor. While this protein facilitates essential blood flow to the new organ, it can also promote the formation of new blood vessels which feed tumor growth, according to the researchers.

"It may be that anti-VEGF agents given judiciously after transplantation can reduce future cancer occurrence," said study senior author Soumitro Pal, assistant professor at Harvard Medical School's Transplantation Research Center at Children's Hospital in Boston, in a news release from the American Association for Cancer Research. "... Once the organ has stabilized, it may be possible to lower the level of VEGF expression to prevent tumor growth. We would need to figure out how to balance benefit and risk to keep cancer at bay."

Pal and his colleagues implanted human kidney cancer cells into mice, then gave the rodents cyclosporine, an immunosuppressant drug often used after transplants. Mice that received the drug grew tumors at a faster rate than mice left untreated.

But the researchers also found a potential solution to the problem: Giving targeted anti-VEGF therapy reduced the pace of growth.

Cyclosporine seems to promote the growth of cancer by activating different forms of protein kinase C, which, in turn, stimulates VEGF production, the researchers said.

More information

For more on organ and tissue donation, visit organdonor.gov.



-- HealthDay Staff



SOURCE: American Association for Cancer Research, news release, July 15, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Tufts researchers discover link between DNA palindromes and disease
2. Researchers hone technique to KO pediatric brain tumors
3. Researchers link Huntingtons disease to overactive immune response in the brain
4. Researchers: Program discourages HIV transmission in Russia
5. Stanford Bio-X researchers use needle-thin probe to get first look at working muscle fiber
6. Researchers design model for automated, wearable artificial kidney
7. Researchers Gather to Address New Tools in Development for Breast Cancer Detection
8. Some drugs increase risk of falling: UNC researchers
9. HIV prevention researchers to compare common ARV as a pill and vaginal gel in unique study
10. Jefferson researchers show antibody to breast cancer-secreted protein blocks metastasis
11. Wake Forest researchers say popular fish contains potentially dangerous fatty acid combination
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... February 09, 2016 , ... Sir ... company , is proud to announce that many of their franchises have received ... service. The hard surface restoration franchises received customer recognition through positive reviews and ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... CURE ... patients, has officially launched the Multiple Myeloma Heroes Awards event , which will ... in the lives of patients with MM. The MM Heroes Awards nomination process ...
(Date:2/8/2016)... ... 08, 2016 , ... Stephanie Hebert Insurance Agency, serving families ... new charity campaign. As part of their ongoing community involvement program, funds are ... that children deserve a voice, and in the spirit of neighbors helping neighbors ...
(Date:2/8/2016)... ... February 08, 2016 , ... If you are feeling that your clothes are ... alone. According to the Center for Disease Control and Prevention (CDC), 34.9% of U.S. ... certain types of cancer, some of the leading causes of preventable death. February ...
(Date:2/8/2016)... ... February 08, 2016 , ... Local insurance agency ... Venice, FL area, has initiated a fundraiser for a two year old little ... days after Christmas. To support this beautiful child who is facing life’s journey ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... 2016 Mast Therapeutics, Inc. (NYSE MKT: ... cell disease and heart failure, today announced that it intends ... common stock in an underwritten public offering.  The offering is ... no assurance as to whether or when the offering may ... of the offering.   --> ...
(Date:2/9/2016)... The global prefilled syringes market accounted for ... to grow with a CAGR of 12.9% during 2015-2020. ... dominated the global prefilled syringes market, with 90.1% share ... The global market of prefilled syringes is up ... population, increasing demand for vaccines, increasing prevalence of chronic ...
(Date:2/9/2016)... The life of Dr. Jan Vilcek , celebrated immunologist ...  Twists of fate, combined with sheer grit, brought him from ... communist Czechoslovakia to New York City ... history by playing a key role in the development of ...  Dr. Vilcek brings readers along his improbable journey in his ...
Breaking Medicine Technology: